Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors.

Stahl D, Gentles AJ, Thiele R, Gütgemann I.

Oncoimmunology. 2019 Oct 13;8(12):e1674113. doi: 10.1080/2162402X.2019.1674113. eCollection 2019.

PMID:
31741777
2.

Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall.

Nowak V, Agaimy A, Kristiansen G, Gütgemann I.

Histopathology. 2020 Jan;76(2):244-250. doi: 10.1111/his.13965. Epub 2019 Nov 26.

PMID:
31373020
3.

[The geriatric syndrome of anemia-Summary of the symposium of the working group anemia during the annual meeting of the German Geriatric Society 2018 in Cologne, Germany].

Röhrig G, Gütgemann I, Gurlit S, Jabs HU, Kolb G, Leischker A.

Z Gerontol Geriatr. 2019 Jul;52(4):370-376. doi: 10.1007/s00391-019-01545-z. Epub 2019 Apr 23. Review. German.

PMID:
31016373
4.

[Anemia in the aged - a geriatric syndrome? : Second position paper on anemia in the aged by the working group anemia of the German Geriatric Society].

Röhrig G, Gütgemann I, Leischker A, Kolb G.

Z Gerontol Geriatr. 2018 Dec;51(8):921-923. doi: 10.1007/s00391-018-1457-x. Epub 2018 Oct 4. Review. German.

PMID:
30284614
5.
6.

Low BUB1 expression is an adverse prognostic marker in gastric adenocarcinoma.

Stahl D, Braun M, Gentles AJ, Lingohr P, Walter A, Kristiansen G, Gütgemann I.

Oncotarget. 2017 Jul 18;8(44):76329-76339. doi: 10.18632/oncotarget.19357. eCollection 2017 Sep 29.

7.

[Current insights into anemia in old age : Summary of the symposium "Anemia in old age" on the occasion of the annual congress of the German Society for Geriatrics (DGG) 2016 in Stuttgart].

Röhrig G, Gütgemann I, von Gersdorff G, Polidori MC, Lupescu A, Lang F, Kolb G.

Z Gerontol Geriatr. 2018 Apr;51(3):343-348. doi: 10.1007/s00391-017-1212-8. Epub 2017 Apr 6. German.

PMID:
28386804
8.

The spleen microenvironment influences disease transformation in a mouse model of KITD816V-dependent myeloproliferative neoplasm.

Pelusi N, Kosanke M, Riedt T, Rösseler C, Seré K, Li J, Gütgemann I, Zenke M, Janzen V, Schorle H.

Sci Rep. 2017 Jan 27;7:41427. doi: 10.1038/srep41427.

9.

The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.

Li J, Riedt T, Goossens S, Carrillo García C, Szczepanski S, Brandes M, Pieters T, Dobrosch L, Gütgemann I, Farla N, Radaelli E, Hulpiau P, Mallela N, Fröhlich H, La Starza R, Matteucci C, Chen T, Brossart P, Mecucci C, Huylebroeck D, Haigh JJ, Janzen V.

Blood. 2017 Jan 26;129(4):460-472. doi: 10.1182/blood-2016-05-714659. Epub 2016 Sep 28.

PMID:
27683414
10.

MYC regulates the antitumor immune response through CD47 and PD-L1.

Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW.

Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10. Erratum in: Science. 2016 Apr 8;352(6282). pii: aaf7984. doi: 10.1126/science.aaf7984.

11.

Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.

Schäfer MH, Lingohr P, Sträßer A, Lehnen NC, Braun M, Perner S, Höller T, Kristiansen G, Kalff JC, Gütgemann I.

Hum Pathol. 2015 Oct;46(10):1488-95. doi: 10.1016/j.humpath.2015.06.007. Epub 2015 Jun 23.

PMID:
26239623
12.

Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver.

Haas N, Riedt T, Labbaf Z, Baßler K, Gergis D, Fröhlich H, Gütgemann I, Janzen V, Schorle H.

Cell Death Differ. 2015 May;22(5):790-800. doi: 10.1038/cdd.2014.172. Epub 2014 Oct 17.

13.

Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer.

Morales-Kastresana A, Labiano S, Gütgemann I, Melero I.

Oncoimmunology. 2014 Jan 16;3:e27812. eCollection 2014.

14.

Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms.

Niebel D, Kirfel J, Janzen V, Höller T, Majores M, Gütgemann I.

Blood. 2014 Jul 3;124(1):151-2. doi: 10.1182/blood-2014-04-569525. No abstract available.

PMID:
24993879
15.

Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.

Morales-Kastresana A, Sanmamed MF, Rodriguez I, Palazon A, Martinez-Forero I, Labiano S, Hervas-Stubbs S, Sangro B, Ochoa C, Rouzaut A, Azpilikueta A, Bolaños E, Jure-Kunkel M, Gütgemann I, Melero I.

Clin Cancer Res. 2013 Nov 15;19(22):6151-62. doi: 10.1158/1078-0432.CCR-13-1189. Epub 2013 Sep 12.

16.

Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis.

Peng WM, Maintz L, Allam JP, Raap U, Gütgemann I, Kirfel J, Wardelmann E, Perner S, Zhao W, Fimmers R, Walgenbach K, Oldenburg J, Schwartz LB, Novak N.

Blood. 2013 Sep 5;122(10):1779-88. doi: 10.1182/blood-2012-12-469882. Epub 2013 Jul 18.

PMID:
23869086
17.

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.

Lehnen NC, von Mässenhausen A, Kalthoff H, Zhou H, Glowka T, Schütte U, Höller T, Riesner K, Boehm D, Merkelbach-Bruse S, Kirfel J, Perner S, Gütgemann I.

Histopathology. 2013 Aug;63(2):157-66. doi: 10.1111/his.12115. Epub 2013 Jun 28. Erratum in: Histopathology. 2013 Dec;63(6):886.

PMID:
23808822
18.

Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI.

Penner AH, Sprinkart AM, Kukuk GM, Gütgemann I, Gieseke J, Schild HH, Willinek WA, Mürtz P.

Eur Radiol. 2013 Oct;23(10):2773-83. doi: 10.1007/s00330-013-2869-z. Epub 2013 May 11.

PMID:
23666233
19.

Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.

Khristi J, Mey U, Kirfel J, Schmidt-Wolf IG, Gütgemann I.

Ann Hematol. 2013 Nov;92(11):1565-7. doi: 10.1007/s00277-013-1742-0. Epub 2013 Apr 5. Review. No abstract available.

PMID:
23558907
20.

Sorafenib in patients with refractory or recurrent multiple myeloma.

Yordanova A, Hose D, Neben K, Witzens-Harig M, Gütgemann I, Raab MS, Moehler T, Goldschmidt H, Schmidt-Wolf IG.

Hematol Oncol. 2013 Dec;31(4):197-200. doi: 10.1002/hon.2043. Epub 2013 Mar 15.

PMID:
23494836
21.

Alterations of global histone H4K20 methylation during prostate carcinogenesis.

Behbahani TE, Kahl P, von der Gathen J, Heukamp LC, Baumann C, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Ellinger J.

BMC Urol. 2012 Mar 13;12:5. doi: 10.1186/1471-2490-12-5.

22.

Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.

Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S.

Cancer Invest. 2012 Feb;30(2):92-7. doi: 10.3109/07357907.2011.636117. Epub 2011 Dec 7.

PMID:
22149091
23.

Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.

Seitz V, Butzhammer P, Hirsch B, Hecht J, Gütgemann I, Ehlers A, Lenze D, Oker E, Sommerfeld A, von der Wall E, König C, Zinser C, Spang R, Hummel M.

PLoS One. 2011;6(11):e26837. doi: 10.1371/journal.pone.0026837. Epub 2011 Nov 10.

24.

H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1.

Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I.

Hum Pathol. 2010 Feb;41(2):181-9. doi: 10.1016/j.humpath.2009.08.007. Epub 2009 Nov 6.

PMID:
19896696
25.

Global levels of histone modifications predict prostate cancer recurrence.

Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, von Ruecker A.

Prostate. 2010 Jan 1;70(1):61-9. doi: 10.1002/pros.21038.

PMID:
19739128
26.

Lymph node dissection in primary intrahepatic malignant mesothelioma: case report and implications for diagnosis and therapy.

Buchholz BM, Gütgemann I, Fischer HP, Gorschlüter M, Türler A, Kalff JC, Hirner A, Standop J.

Langenbecks Arch Surg. 2009 Nov;394(6):1123-30. doi: 10.1007/s00423-009-0476-x. Epub 2009 Mar 12.

PMID:
19280219
27.

Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulation.

Ney JT, Schmidt T, Kurts C, Zhou Q, Eckert D, Felsher DW, Schorle H, Knolle P, Tüting T, Barchet W, Büttner R, Limmer A, Gütgemann I.

Hepatology. 2009 Feb;49(2):471-81. doi: 10.1002/hep.22652. Erratum in: Hepatology. 2009 Mar;49(3):1058.

PMID:
19105207
28.

Stem cell marker expression in small cell lung carcinoma and developing lung tissue.

Koch LK, Zhou H, Ellinger J, Biermann K, Höller T, von Rücker A, Büttner R, Gütgemann I.

Hum Pathol. 2008 Nov;39(11):1597-605. doi: 10.1016/j.humpath.2008.03.008. Epub 2008 Jul 24.

PMID:
18656241
29.

Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.

Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, Sörensen I, Steinmetz H, Kubicka S, Carlomagno T, Menche D, Gütgemann I, Buer J, Gossler A, Manns MP, Kalesse M, Frank R, Malek NP.

Cancer Cell. 2008 Jul 8;14(1):23-35. doi: 10.1016/j.ccr.2008.05.016.

30.

Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma.

Gütgemann I, Lehman NL, Jackson PK, Longacre TA.

Mod Pathol. 2008 Apr;21(4):445-54. doi: 10.1038/modpathol.3801022. Epub 2008 Jan 18.

31.

VEGF and osteosclerosis in POEMS syndrome.

Gütgemann I, Stevens K, Loftus D, Schmidt-Wolf IG, George TI.

Ann Hematol. 2008 Mar;87(3):243-5. doi: 10.1007/s00277-007-0425-0. Epub 2008 Jan 3. No abstract available.

PMID:
18172647
32.

Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.

Shimomura A, Lilienfeld-Toal Mv, Balta Z, Schroers E, Schmidt-Wolf IG, Büttner R, Rücker Av, Gütgemann I.

Ann Hematol. 2008 Mar;87(3):255-6. Epub 2007 Oct 5. No abstract available.

PMID:
17917728
33.

Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.

Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schäfer N, Höller TT, Fischer HP, Büttner R, Gütgemann I.

Hum Pathol. 2007 Nov;38(11):1621-7. Epub 2007 Jul 24.

PMID:
17651785
34.

Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.

Haas S, Gütgemann I, Wolff M, Fischer HP.

Am J Surg Pathol. 2007 Jun;31(6):902-6.

PMID:
17527078
35.

Hodgkin's lymphoma in a patient with Jo-1 syndrome.

Adam AC, Grohé C, Stier S, Gattenlöhner S, Balta Z, Büttner R, Gütgemann I.

Virchows Arch. 2007 Jul;451(1):101-4. Epub 2007 May 24.

PMID:
17522890
36.

[Castleman's disease in ear, nose, and throat practice].

Schrock A, Gutgemann I, Keiner S.

HNO. 2007 May;55 Suppl 1:E29-32. Review. German.

PMID:
17262216
37.

Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.

Ney JT, Zhou H, Sipos B, Büttner R, Chen X, Klöppel G, Gütgemann I.

Hum Pathol. 2007 Feb;38(2):359-64. Epub 2006 Nov 29.

PMID:
17137615
38.

Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance.

Engel D, Dobrindt U, Tittel A, Peters P, Maurer J, Gütgemann I, Kaissling B, Kuziel W, Jung S, Kurts C.

Infect Immun. 2006 Nov;74(11):6100-7. Epub 2006 Sep 11.

39.

Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.

Heukamp LC, Fischer HP, Schirmacher P, Chen X, Breuhahn K, Nicolay C, Büttner R, Gütgemann I.

Histopathology. 2006 Sep;49(3):242-7.

PMID:
16918970
40.

Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.

Tormo D, Ferrer A, Gaffal E, Wenzel J, Basner-Tschakarjan E, Steitz J, Heukamp LC, Gütgemann I, Buettner R, Malumbres M, Barbacid M, Merlino G, Tüting T.

Am J Pathol. 2006 Aug;169(2):665-72.

41.

Primary intrahepatic malignant mesothelioma of epithelioid type.

Gütgemann I, Standop J, Fischer HP.

Virchows Arch. 2006 May;448(5):655-8. Epub 2006 Mar 16.

PMID:
16541281
42.

CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.

Gütgemann I, Haas S, Berg JP, Zhou H, Büttner R, Fischer HP.

Virchows Arch. 2006 Apr;448(4):407-11. Epub 2006 Jan 13.

PMID:
16411132
43.

The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.

Wenzel J, Gütgemann I, Distelmaier M, Uerlich M, Mikus S, Bieber T, Tüting T.

J Am Acad Dermatol. 2005 Sep;53(3):422-7.

PMID:
16112347
44.

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X.

Carcinogenesis. 2005 Dec;26(12):2050-7. Epub 2005 Jul 6.

PMID:
16000397
45.

A blood-borne antigen induces rapid T-B cell contact: a potential mechanism for tolerance induction.

Gütgemann I, Darling JM, Greenberg HB, Davis MM, Chien YH.

Immunology. 2002 Dec;107(4):420-5.

46.

A population of murine gammadelta T cells that recognize an inducible MHC class Ib molecule.

Crowley MP, Fahrer AM, Baumgarth N, Hampl J, Gutgemann I, Teyton L, Chien Y.

Science. 2000 Jan 14;287(5451):314-6.

47.

Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen.

Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH.

Immunity. 1998 Jun;8(6):667-73.

48.

Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface.

Beeson C, Rabinowitz J, Tate K, Gütgemann I, Chien YH, Jones PP, Davis MM, McConnell HM.

J Exp Med. 1996 Aug 1;184(2):777-82.

49.

Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes.

Günther M, Haubeck HD, van de Leur E, Bläser J, Bender S, Gütgemann I, Fischer DC, Tschesche H, Greiling H, Heinrich PC, et al.

Arthritis Rheum. 1994 Mar;37(3):395-405.

PMID:
8129795

Supplemental Content

Loading ...
Support Center